We are a pre-clinical stage startup innovating drug delivery systems (DDS) based on a simple-mixing, self-assembling porous hydrogel without chemical cross-linking. Our technology can deliver a variety of active pharmaceutical ingredients (APIs) with controlled release and long-lasting effects. Our drug-loaded gel offers multiple injection routes, custom formulations with slow-release kinetics, and the ability to mix multiple APIs. As a GMP clinical-grade DDS, we aim to transform therapeutics across various clinical settings.
We are developing solutions for complex indications like solid tumours while actively seeking partnerships to expand the application of our platform. Join us in shaping the future of targeted, controlled-release therapeutics.
Injectable DDS
The drug loaded porous hydrogel matrix can be injected into various body sites, including:
• Intradermal (into the skin)
• Tissues
• Organs
• Intra-articular joints (within joints)
• Tumours
Topical DDS
The drug loaded porous hydrogel can also applied topically for skin conditions like psoriasis. Our platform addresses critical challenges in treating psoriasis and atopic dermatitis by combining multiple therapeutic agents in a novel formulation that enables precise, controlled drug delivery through topical application
Company Details
- Employees
- 4
- Founded
- -
- Address
- Oxford, Gb
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.pnastx.com/
- Keywords
- Multiple API formulation, Drug Delivery Systems (DDS), Advanaced Therapeutics, Comple Medicine, Controlled release drugs, nanogel.
- HQ
- Oxford
Pnas Therapeutics Questions
Pnas Therapeutics's website is https://www.pnastx.com/
Pnas Therapeutics's LinkedIn profile is https://uk.linkedin.com/company/pnas-therapeutics
Pnas Therapeutics has
4 employees.
View email and phone details for 4
employees at Pnas Therapeutics.
Pnas Therapeutics's industry is
Biotechnology Research
Pnas Therapeutics's top competitors are
Assuredrop,
Biorevert Inc.,
Nyschey Ltd,
Rokalin Biosystems,
Pnaseer Inc.,
Bio-Research.ai,
Chariot Biosciences,
Exonostic,
Deepinfinity.ai,
Qinara.
Pnas Therapeutics's categories are Biotechnology Research
Pnas Therapeutics's founding year is 2024
